
PBD Biotech secures £2.3m funding for OIE validation of its rapid, accurate bovine TB test
PBD Biotech gains £2.3m funding to take Actiphage through to OIE validation, a requirement for international adoption of this diagnostic for mycobacterial diseases including bTB, Johne’s Disease and human TB